Characteristics of clinician input in Canadian funding decisions for cancer drugs: a cross-sectional study based on CADTH reimbursement recommendations.

ABSTRACT:

Objective

To examine characteristics of clinician input to the pan-Canadian Oncology Drug Review (pCODR) for cancer drug funding recommendations from 2016 to 2020.

Design, setting and participants

Descriptive, cross-sectional study including 62 reimbursement decisions from pCODR from 2016 to 2020.

Interventions

pCODR recommendations were analysed for the number of clinicians consulted on each submission, affiliation, number of submissions per clinician, declared financial conflicts of interest (FCOIs), randomisation, type of blinding, primary endpoint, study phase, and whether the study demonstrated improvement in overall survival (OS) and progression-free survival (PFS).

Main outcome measures

The main outcome was clinician support for the initial funding recom

SUBMITTER: Jenei K 

PROVIDER: S-EPMC10583055 | biostudies-literature | 2023 Oct

REPOSITORIES: biostudies-literature